SNAP Biosciences, a subsidiary of Coeptis Therapeutics Holdings, has entered into a licensing agreement with Monarch Therapeutics to develop and commercialize its Snap-Car NK cell therapy platform for ...

Imagine "Shark Tank," but all medical and life science companies pitching innovative life-saving ideas. It's exactly what Indiana University Launch Accelator for Biosciences and venture capitalist, ...